Brief: Aquestive Therapeutics Reports Full Year 2023 Financial Results
05/03/2024 22:12
March 5 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* AQUESTIVE THERAPEUTICS REPORTS FULL YEAR 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* AQUESTIVE THERAPEUTICS INC - SEES 2024 TOTAL REVENUE $48
MILLION
TO $51 MILLION
Source text for Eikon: ID:nGNXfDTHv
Further company coverage: AQST.O
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma